TERT gene
The TERT gene provides instructions for the hTERT component of telomerase, which is essential for maintaining telomere length and protecting chromosome integrity.
Overview
The TERT gene provides instructions for making the hTERT component of the enzyme telomerase. Working alongside the hTR component (produced by the TERC gene), hTERT adds repeated DNA segments to the ends of chromosomes, known as telomeres. Telomeres protect chromosomes from degradation. As cells divide, telomeres naturally shorten; telomerase activity prevents this shortening in rapidly dividing cells. Abnormally high telomerase activity is a hallmark of most cancer cells, allowing them to divide uncontrollably.
Health Conditions Related to Genetic Changes
Dyskeratosis congenita
Mutations in the TERT gene cause the hTERT protein to become unstable or dysfunctional, leading to shortened telomeres. This results in symptoms such as nail dystrophy, oral leukoplakia, and skin pigmentation changes, as well as an increased risk of bone marrow failure, pulmonary fibrosis, and cancer.
Idiopathic pulmonary fibrosis
Mutations in the TERT gene are linked to idiopathic pulmonary fibrosis. The resulting telomerase deficiency causes telomeres to shorten prematurely, leading to lung cell damage and scarring. This condition is often influenced by both genetic factors and environmental exposures.
Cancers and Other Disorders
- Melanoma and Acute Myeloid Leukemia: Mutations in the TERT gene are associated with an increased risk of these cancers, likely due to impaired telomere maintenance leading to DNA damage and uncontrolled cell growth.
- Isolated Aplastic Anemia: Mutations can lead to bone marrow failure without the other physical features of dyskeratosis congenita, potentially representing a late-onset form of the disorder.
Other Names for This Gene
- EST2
- hEST2
- TCS1
- telomerase catalytic subunit
- telomerase-associated protein 2
- TERT_HUMAN
- TP2
- TRT
